Ex-President Joe Biden’s former chief of staff ignored reporters on his way out of an interview with congressional investigators on Thursday after a marathon grilling behind closed doors. Ronald Klain served as White House chief…
-
-
As part of his effort to ‘Make America Safe Again,’ President Donald Trump signed an executive order to allow cities and states to remove homeless people off the streets and into treatment centers. Trump signed…
-
Writing in the New York Times on Monday, longtime Democratic political strategist James Carville outlined a compelling message for Democrats to unite around ahead of the 2026 midterms. Carville urged Democrats to delay the ‘civil…
-
Investor Insight In an increasingly eco-conscious global market, Carbonxt presents a compelling investment case, leveraging a growing addressable market driven by strategic partnerships and regulatory changes that are set to drive demand for activated carbon…
-
The simultaneous listing of the xU3O8 token across major cryptocurrency trading venues: KuCoin, MEXC, and Gate.com has been announced today. This multi-platform launch marks a significant milestone in real-world asset (RWA) tokenization, bringing institutional-grade uranium…
-
Investor Insight Purpose-built for today’s energy transition, xU3O8 sits at the intersection of technology, finance, and nuclear energy, offering a simplified and transparent alternative to legacy uranium investments amid surging global demand. The xU3O8 token,…
-
Glencore (LSE:GLEN,OTC Pink:GLCNF) is preparing to shut down its final two Australian copper mines next week, ending more than six decades of upstream operations in Queensland. The closure of the underground Enterprise and X41 mines…
-
Galan Lithium (GLN:AU) has announced Incentive Regime for HMW Project in Argentina Download the PDF here. This post appeared first on investingnews.com
-
Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector is home to companies pursuing cutting-edge therapies and medical technologies. According to Grandview Research, the global…
-
The second quarter of 2025 was a period of dynamic evolution within the biotechnology and pharmaceutical sectors. Critical factors like escalating policy pressures, pipeline pivots by leading companies and the increasingly transformative impact of artificial…